Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci

NCT02411331 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Lock Solution
Catheter Related Blood Stream Infections
Central Venous Catheter Infection
Intravenous Drug Delivery Systems
Coagulase-negative Staphylococci Infection

Interventions

DRUG: Ethanol 40% + Enoxaparine 400UI/ml
DRUG: Vancomycine 5 mg/ml + Héparine 2500UI/ml

Sponsor

University Hospital, Clermont-Ferrand

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]